Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsAssociation among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel diseaseEx vivo host and parasite response to antileishmanial drugs and immunomodulatorsComparative proteomics study reveals that bacterial CpG motifs induce tumor cell autophagy in vitro and in vivoThe effect of TLR9 agonist CpG oligodeoxynucleotides on the intestinal immune response of cobia (Rachycentron canadum).Porcine small intestinal epithelial cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate immune responses to rotaviruses and probioticsTargeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses.Transcript levels of Toll-Like Receptors 5, 8 and 9 correlate with inflammatory activity in Ulcerative Colitis.The role of bacteria and pattern-recognition receptors in Crohn's disease.IL-10-dependent partial refractoriness to Toll-like receptor stimulation modulates gut mucosal dendritic cell function.Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers.Expression of Toll-like receptors 2 and 9 in cells of dog jejunum and colon naturally infected with Leishmania infantum.CpG-Oligodeoxynucleotide Treatment Protects against Ionizing Radiation-Induced Intestine Injury.Prevention of CpG-induced pregnancy disruption by adoptive transfer of in vitro-induced regulatory T cells.Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells.Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in miceAugmentation of autologous T cell reactivity with acute myeloid leukemia (AML) blasts by Toll-like receptor (TLR) agonistsIntestinal microvascular endothelium and innate immunity in inflammatory bowel disease: a second line of defense?No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammationTriggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack.Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.Differential effects of the CpG-Toll-like receptor 9 axis on pregnancy outcome in nonobese diabetic mice and wild-type controls.Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment.Transcriptomic Insights into the Response of Placenta and Decidua Basalis to the CpG Oligodeoxynucleotide Stimulation in Non-Obese Diabetic Mice and Wild-Type ControlsClinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes.The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis.Toll-like receptor 9 agonists as cancer therapeutics.Toll-like receptor agonists: a patent review (2011 - 2013).Dinucleotide Composition in Animal RNA Viruses Is Shaped More by Virus Family than by Host Species.Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.Triggering receptor expressed on myeloid cells-1 (TREM-1) expression on gastric epithelium: implication for a role of TREM-1 in Helicobacter pylori infection.ERK activation drives intestinal tumorigenesis in Apc(min/+) mice.Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA.Role of Toll-like receptors in health and diseases of gastrointestinal tract.Expression of Toll-like receptors in the mucosa of patients with ulcerative colitis.Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.Expression and function of toll-like receptor 8 and Tollip in colonic epithelial cells from patients with inflammatory bowel disease.Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer.The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease.
P2860
Q21131205-838DE87A-3452-4908-B5B7-D2DA0CBB41C5Q27006589-D0F1C392-4A6F-4F2B-A6FC-7A4321FA03BAQ28547648-A8D45E9F-8981-4429-8D34-64BDF69C5967Q28582844-541D3B19-1A7D-4DA5-9A7E-E3BC60C20981Q31171481-90B0651A-59E6-40FE-BECC-E40C168DA598Q33905223-AFCF27D7-ABDE-449E-B630-6F30FE260BCBQ34048648-2533395F-EEBA-42F7-AAC4-D74AF5435817Q34106945-ADAB0EDB-2F20-4B3F-94F5-DF6C02C8C6C2Q34163374-B9C76398-AC37-47B9-BAD4-CB1E95C246D2Q34333969-83D91229-6C25-454B-BB01-1EDBBE85FC90Q34619324-984DEFA0-FDE8-41CC-B40F-5B4E9CEA5811Q34719048-6008EB3A-A779-4E8C-A217-9BE2BA481FF0Q34785434-A0A0FAB5-FFFD-4241-85F0-2A6A20DB90AEQ35143080-B13DB58B-1970-49D8-A437-A10604D639FEQ35571128-5819F023-7B0A-45C7-9429-A3BCC18C86B5Q36403509-E76A56E5-3A2D-4A17-8CCC-EEEB6457A3BFQ36546862-F0149057-3030-4E46-B262-D5E13E42A363Q36599369-7AD721A4-F94F-4867-ABBB-7758377A3AA3Q36732312-2775E190-846C-4EA3-A600-1CD393817374Q37002943-1973B80F-4B28-44FB-BBE0-815B8C5FD8F6Q37050998-17746D6A-18CF-4352-8D00-F2FB3DE00685Q37130691-FFFBE65C-F700-497D-9857-B7F0AE7187F6Q37177507-18A2D614-E812-401A-B580-A4F8045662FFQ37210044-E0E7B85F-8A0F-4431-B21D-B96F897356A5Q37387994-BA99372D-35F5-45C3-8123-50CA0F5B8E57Q37447389-6F500F48-80A2-4010-B842-7AD3BA35F2DAQ37627550-62C92BA9-8A60-4623-9FA2-83D32C4DBAAEQ37831323-C6F4E513-BD9F-427E-B5A8-1781807F4176Q38181176-796387FD-A5B1-46BF-B789-D4DB2AE9F0E1Q38985722-517D9897-81F6-420B-A17B-DE56AE6882C6Q39896496-96AF9F8E-F188-41D1-B28B-EE6137DB1A37Q40005740-579328CB-783D-4CF0-AB85-DEFBE6D17A9EQ40941552-AD221B69-1342-4186-A66B-42E3BC0B3ACAQ41943483-184A1068-D7D6-4988-8E35-3025AA232CA3Q42726049-EB64E9BD-2712-482A-9984-6C87EB1DD1F1Q43180773-6CCCD2F6-085B-47D0-B3F6-D522543BCE5CQ43189281-EE894311-DB97-436D-A736-C8376EDB45E4Q43429839-E293F0C7-E09F-4D79-8B18-039E795F8A0BQ43774171-6F7E43EF-2AD0-455A-BEEA-BC8E827DA868Q47109861-105A6ABD-76AB-4A90-B294-6F3466B53D4A
P2860
Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Expression of Toll-like recept ...... n human intestinal epithelium.
@en
type
label
Expression of Toll-like recept ...... n human intestinal epithelium.
@en
prefLabel
Expression of Toll-like recept ...... n human intestinal epithelium.
@en
P2093
P2860
P1476
Expression of Toll-like recept ...... in human intestinal epithelium
@en
P2093
G Pedersen
J Brynskov
J Rask-Madsen
M W Matthiessen
P2860
P304
P356
10.1111/J.1365-2249.2005.02848.X
P577
2005-08-01T00:00:00Z